legislation: 117-hr-9321
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117-hr-9321 | 117 | hr | 9321 | Independent Drug Value Assessment Act | Health | 2022-11-16 | 2022-11-17 | Referred to the Subcommittee on Health. | House | Rep. Speier, Jackie [D-CA-14] | CA | D | S001175 | 2 | Independent Drug Value Assessment Act This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system). | 2023-08-15T15:45:20Z |